Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombolytic therapy in children.

Manuela Albisetti1

  • 1Division of Hematology, University Children's Hospital, Steinwiesstrasse 75, CH-8032 Zurich, Switzerland. manuela.albisetti@kispi.unizh.ch

Thrombosis Research
|May 20, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Outcomes of Efanesoctocog Alfa Prophylaxis in Children With Severe Haemophilia A: Interim Data From XTEND-ed.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same author

Expanding Horizons in Thrombosis and Hemostasis: From Molecular Determinants to Real-World and Expert Opinion Evidence.

Hamostaseologie·2026
Same author

The Swiss Haemophilia Registry-Report From the First 8 Years.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same author

From Case Reports to Cohort Studies: The Many Faces of Clinical Research in Thrombosis and Haemostasis.

Hamostaseologie·2026
Same author

Hemophilia Severity and Its Association With Mental Health and Health-Related Quality of Life-Results From a Cross-Sectional Multicenter Study.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same author

Connecting the Dots: Reflections on a vibrant Year in Haemostasis Research.

Hamostaseologie·2026
Same journal

Apoptotic versus procoagulant platelets: similar "necrotic" phenotype and procoagulant activity in vitro, but distinct adhesive protein composition.

Thrombosis research·2026
Same journal

Heatstroke-induced coagulopathy: A scoping review of therapeutic strategies and outcome reporting.

Thrombosis research·2026
Same journal

Mapping thrombus habitat: Non-contrast MRI radiomics and pixel-tile histomics approach to track venous thrombosis evolution in mice.

Thrombosis research·2026
Same journal

A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study.

Thrombosis research·2026
Same journal

Associating the phenotypic expression of platelets with disease type through image-based single-cell profiling.

Thrombosis research·2026
Same journal

The mechanisms of contractile dysfunction following chronic limited platelet activation in (pro)thrombotic conditions.

Thrombosis research·2026
See all related articles

Thrombolysis is a growing treatment for pediatric thromboembolic events. This review clarifies indications, efficacy, safety, and dosing for thrombolytic agents in newborns and children.

Area of Science:

  • Pediatric critical care medicine
  • Neonatal medicine
  • Pediatric cardiology

Background:

  • Thrombolysis is an emerging treatment for pediatric arterial and venous thromboembolic events.
  • Occluded central venous lines in children also present a challenge.
  • Lack of uniform guidelines complicates thrombolytic therapy in pediatric patients.

Purpose of the Study:

  • To summarize current information on thrombolytic agents in pediatric populations.
  • To review potential indications, efficacy, and safety profiles.
  • To examine evidence supporting dosing schedules for thrombolysis in newborns and children.

Main Methods:

  • Literature review of studies on thrombolytic agents in pediatric patients.
  • Analysis of data regarding indications, drug choice, administration routes, and dosing.

Related Experiment Videos

  • Evaluation of reported outcomes, including therapeutic effectiveness and bleeding complications.

    • Main Results:

    • Varied protocols exist for different thrombolytic agents, impacting outcomes.
    • Effectiveness and bleeding risks differ based on current practices.
    • Limited standardized recommendations necessitate careful consideration of individual cases.

    Conclusions:

    • Thrombolysis offers a viable treatment option for pediatric thromboembolic conditions.
    • Further research and standardized guidelines are needed to optimize pediatric thrombolytic therapy.
    • Evidence-based protocols are crucial for improving efficacy and minimizing risks in children.